Table 1.
Demographic and Baseline Values
| Completed Study | Failed to Complete Study* | ||
|---|---|---|---|
| Age | 62 (±10) | 57 (±9) | |
| Sex (female) | 22 (55%) | 16 (67%) | |
| Amount Injected (mg/ml)† | 40 (20–120) | 40 (40–120) | |
| Fasting BG Level (mg/dl) | 138 (43) | Not available | |
| Diabetes Mellitus | |||
| Type 1 | 7 (18%) | 7 (29%) | |
| Type 2 | 33 (82%) | 18 (71%) | |
| HbA1C | 7.1 (6-10) | 7.5 (6-11) | |
| Medication Type | |||
| Insulin | 17 (43%) | 11 (46%) | |
| Oral Meds Only | 19 (47%) | 12 (50%) | |
| Diet Only | 4 (10%) | 1 (4%) | |
| Injection location‡ | |||
| Tendon Sheath | 28 (70%) | 23 (96%) | |
| Joint | 10 (25%) | 1 (4%) | |
| Other§ | 2 (5%) | -- | |
*
Data available for 24 of 27 excluded participants
†
Data not normal, mode value reported
‡
23 Trigger finger, 3 DeQuervain’s, 1 CTS, 1 Unknown; all 10 joints were injected for OA
§
Injections in both Tendon Sheath and Joint